At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Closed Mourning Day 01-08 16:00:00 EST
1,248.05
-16.69
-1.32%
High1,265.78Low1,246.28Vol106.79M
Open1,264.65D1 Closing1,264.73Amplitude1.54%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O977.08MT/O Rate--Tradable Shares0.00
P/B3.157523ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Inovio CEO sees 2025 to be ‘transformational year’
TIPRANKS  ·  43 minutes ago
Inovio CEO sees 2025 to be ‘transformational year’
INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
PR Newswire  ·  21:04
INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
ACCESSWIRE  ·  05:30
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Emergent BioSolutions Receives $20 Million Contract to Supply Anthrax Vaccine to US Military
MT Newswires Live  ·  00:27
Emergent BioSolutions Receives $20 Million Contract to Supply Anthrax Vaccine to US Military
BRIEF-Quest Diagnostics Names Adrienne Brott Senior Vice President And Chief Quality And Regulatory Affairs Officer
Reuters  ·  01-08 22:31
BRIEF-Quest Diagnostics Names Adrienne Brott Senior Vice President And Chief Quality And Regulatory Affairs Officer
BRIEF-Aethlon Medical Granted 180-Day Extension To Regain Nasdaq Compliance
Reuters  ·  01-08 22:16
BRIEF-Aethlon Medical Granted 180-Day Extension To Regain Nasdaq Compliance
GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
NewMediaWire  ·  01-08 22:00
GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025
Quest Diagnostics names Adrienne Brott Chief Quality, Regulatory Affairs Officer
TIPRANKS  ·  01-08 21:45
Quest Diagnostics names Adrienne Brott Chief Quality, Regulatory Affairs Officer
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
THOMSON REUTERS  ·  01-08 21:42
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
Press Release: Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
Dow Jones  ·  01-08 21:42
Press Release: Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
Aethlon Medical Inc - Granted 180-Day Extension to Regain Nasdaq Compliance With Minimum Bid Price Requirement
THOMSON REUTERS  ·  01-08 21:26
Aethlon Medical Inc - Granted 180-Day Extension to Regain Nasdaq Compliance With Minimum Bid Price Requirement
BRIEF-Tonix Pharmaceuticals Expects Topline Data For Tnx-1300 In Q3 2025, TNX-1500 In Q1 2025
Reuters  ·  01-08 20:56
BRIEF-Tonix Pharmaceuticals Expects Topline Data For Tnx-1300 In Q3 2025, TNX-1500 In Q1 2025
BRIEF-Emergent Biosolutions Announces Exercise Of $20 Million Option To Supply U.S. Department Of Defense With Biothrax
Reuters  ·  01-08 20:49
BRIEF-Emergent Biosolutions Announces Exercise Of $20 Million Option To Supply U.S. Department Of Defense With Biothrax
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
GlobeNewswire  ·  01-08 20:45
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
Tonix Pharmaceuticals Holding Corp - Expects Topline Data for Tnx-1300 in Q3 2025, Tnx-1500 in Q1 2025
THOMSON REUTERS  ·  01-08 20:40
Tonix Pharmaceuticals Holding Corp - Expects Topline Data for Tnx-1300 in Q3 2025, Tnx-1500 in Q1 2025
Emergent BioSolutions exercises $20M option to supply DoD with BioThrax
TIPRANKS  ·  01-08 20:35
Emergent BioSolutions exercises $20M option to supply DoD with BioThrax
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense With Biothrax® (Anthrax Vaccine Adsorbed)
THOMSON REUTERS  ·  01-08 20:30
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense With Biothrax® (Anthrax Vaccine Adsorbed)
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
GlobeNewswire  ·  01-08 20:30
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40%
MT Newswires Live  ·  01-08 20:16
Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40%
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team With Appointment of Gary Ainsworth as Vice President of Market Access
THOMSON REUTERS  ·  01-08 20:00
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team With Appointment of Gary Ainsworth as Vice President of Market Access

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--